Earnings Feed
Start Free
Home/Insiders/Danziger Asaf
DA
SEC Insider//CIK 0001654435

Danziger Asaf

CIK 00016544351 companyWAYNE, PA
SEC Profile

Transactions

50

Companies

1

Filings

6

CIK

0001654435

Recent Transactions

50 trades
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2025-12-31$10.99/sh+1→ 416,474 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2025-06-30$15.13/sh+833→ 416,473 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2025-01-01+400,000→ 415,640 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2024-12-31$14.75/sh+412→ 15,640 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2024-06-28$12.24/sh+1,239→ 15,228 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-06-30$35.28/sh+367→ 13,989 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-01-06$62.30/sh+39→ 13,622 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2023-01-05−25,000→ 0 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-01-05$118.47/sh−2,123→ 15,427 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-01-05$115.21/sh−3,702→ 19,944 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-01-05$108.00/sh−187,500→ 13,583 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-01-05$117.01/sh−999→ 17,550 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-01-05$119.99/sh−500→ 13,583 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2023-01-05−187,500→ 0 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-01-05$112.86/sh−2,000→ 28,214 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-01-05$111.23/sh−8,369→ 30,214 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-01-05$7.15/sh+187,500→ 201,083 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-01-05$116.06/sh−1,395→ 18,549 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-01-05$119.35/sh−1,344→ 14,083 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-01-05$11.46/sh+25,000→ 38,583 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-01-05$114.35/sh−4,568→ 23,646 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2022-07-05$59.08/sh+276→ 13,583 total
  • Award
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2022-03-03$80.59/sh+13,470→ 13,470 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2022-01-06$63.82/sh+31→ 13,307 total
  • Purchase
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-11-26$96.50/sh+104→ 13,276 total
  • Purchase
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-11-26$103.37/sh+1,000→ 13,172 total
  • Purchase
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-11-26$102.36/sh+3,870→ 12,172 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-07-06$137.12/sh+118→ 8,302 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-04-13$196.34/sh−97,973→ 8,184 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-02-27$149.10/sh+9,259→ 206,944 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Restricted Stock Units

    2021-02-27−9,259→ 0 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-01-06$50.67/sh+53→ 197,685 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-12-18$162.35/sh−1,700→ 199,539 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-12-18$162.17/sh−1,426→ 200,332 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-12-18$159.32/sh−4,500→ 217,350 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-12-18$156.09/sh−24,286→ 255,689 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-12-18$163.35/sh−536→ 199,003 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-12-18$160.99/sh−3,500→ 201,758 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-12-18$160.25/sh−12,092→ 205,258 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-12-18$158.09/sh−9,183→ 221,850 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-12-18$22.00/sh+103,955→ 301,587 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2020-12-18−103,955→ 103,955 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-12-18$158.06/sh−10,077→ 221,729 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-12-18$156.08/sh−24,973→ 255,407 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-12-18$157.04/sh−24,656→ 231,033 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-12-18$162.97/sh−1,300→ 199,032 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-12-18$155.24/sh−21,612→ 279,975 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-12-18$165.38/sh−700→ 197,832 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-12-18$22.00/sh+103,955→ 301,587 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-12-18$157.01/sh−23,601→ 231,806 total

Companies

1

Recent Filings

6

Address

C/O NOVOCURE INC. 1550 LIBERTY RIDGE DRIVE, SUITE 115

WAYNE, PA, 19087

View on SEC.gov